Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
162000 participants
OBSERVATIONAL
2025-01-09
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Two-level observational retrospective-prospective study was planned. Setting: National multicenter study of surgical inpatients. Patients: Adult patients undergoing elective and emergency surgery. Types of interventions: in obstetrics, in gynecology, on the breast, in urology and kidneys, in endocrine surgery, in maxillofacial surgery, in orthopedics and traumatology, on the lower floor of the abdominal cavity, on the liver and biliary tract, on the upper floor of the abdominal cavity cavities, in thoracic surgery, in vascular surgery, in neurosurgery, in cardiac surgery, in other areas (with mandatory specification).
The study was organized by the Federation of Anesthesiologists and Reanimatologists of Russia. Primary (30-day mortality, 30-day complications) and secondary (hospital mortality, hospital complications, length of stay in anesthesiology, resuscitation and intensive care departments, length of hospital stay, multiple organ failure (2 or more points on the SOFA scale (Sequential)) Organ Failure Assessment), 90-day mortality, 90-day complications, intensive care after-effects syndrome, readmission, 1-year mortality) outcomes were determined. The required sample size and statistical analysis methods are described. The planned duration of the study is 2024-2028.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
NCT03945968
Factors Affecting Surgical Recovery in Hospital Patients
NCT06502600
Risk Factors for Postoperative Complications in Major Non-cardiac Surgery: Post-hoc Analysis of the OPHIQUE Multicentre Study
NCT05824260
Predictive Model for Postoperative Mortality
NCT02947789
Modulation of Microbiota Metabolism in Cardiac Surgery Patients
NCT04921436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Identification of risk factors that cause a high probability of an unfavorable outcome is currently unthinkable without conducting comprehensive prospective population-based studies, which, on the one hand, make it possible to assess the contribution of many variables to the risk of complications and mortality, and on the other hand, to maximally cover a certain population by identifying characteristic predictors for it. To date, several population-based studies and programs have been described in the literature that have led to the creation of national databases (registries) of postoperative outcomes. Such studies include several international (ISOS, EuSOS and ASOS) and national ones, such as SweSOS \[8\] or ColSOS , which are at different stages of implementation. Among the national databases, the best known is the ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program) database, which contains information on the outcomes of surgical treatment for more than 5 million patients in the United States since 1991 .
The results obtained from these studies often vary widely, due to the diversity of approaches to study inclusion criteria, differences in the characteristics of the populations studied, and the lack of a uniform view on the classification of postoperative outcomes. When assessing mortality, the authors most often record 30-day mortality, however, taking into account modern ideas about the role of perioperative factors and complications in the development of an unfavorable long-term outcome, the need to determine one-year mortality becomes obvious. As shown by the national observational study SweSOS, the mortality rate increases significantly over time, with 30-day mortality being 1.8%, 3-month mortality - 3.9%, and 6-month and annual mortality - 5.0% and 8.5% , respectively .
There is also no uniform approach to the registration of postoperative complications, and modern protocols use several systems, the most common of which are the classification of the joint working group of ESA (The European Society of Anesthesiologists) and ESICM (The European Society of Intensive Care Medicine, The European). Society of Intensive Care Medicine) and the ACS-NSQIP classification (The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP)). And although they are similar in many ways (complications are grouped into blocks according to the nature of the disorders), differences are also present, and even the same complication may have a different definition. In addition, some significant outcomes are not included in these classifications, which predetermines their underestimation.
Of course, one of the advantages of creating a large population-based database is the recording of a large number of potential predictors of adverse outcome and subsequent assessment of their individual contribution to the complex perioperative risk. The type of surgical intervention itself is a factor that largely determines the likelihood of complications.
The goal is to create a Russian national calculator for the risk of postoperative complications and mortality.
Primary target points:
1. Creation of a national register of postoperative outcomes in different areas of surgery.
2. Determination of the frequency and structure of outcomes after elective and emergency surgery.
3. Identification of predictors of unfavorable outcome.
4. Development and validation of a model for predicting complications and mortality in various areas of surgery
5. Creation of calculators for the risk of postoperative complications and mortality in various fields of surgery and their integration into a single calculator
6. Analysis of long-term results in patients with postoperative complications (90 days and a year after surgery)
Secondary target points:
1. The role of concomitant diseases in the development of unfavorable outcome
2. The influence of age on primary and secondary postoperative outcomes
3. The influence of the type of anesthesia on the course of the postoperative period
4. The influence of oncological pathology and specific treatment on primary and secondary postoperative outcomes
5. The impact of the urgency of surgery on the risk of an unfavorable outcome
6. Influence of localization, access and duration of surgery on postoperative outcome
7. Assessment and validation of surgical and anesthesiological risk scales for lethal outcome (can be listed)
8. Evaluation and validation of surgical and anesthetic risk scales for primary and secondary outcomes
9. Stratification of patients at high perioperative risk with details on cardiac, respiratory, neurological, renal, hepatic, hemostasiological, infectious and others.
10. Influence of quality criteria for implementation of FAR recommendations on the course of the postoperative period
11. Analysis of the course of ICU-syndrome in patients with complications and depending on the maximum score on the SOFA scale and the structure of MOF in the postoperative period
12. Analysis of the effectiveness of rehabilitation measures in patients with ICU-syndrome
13. Analysis of the causes of mortality (based on autopsy reports and clinical and laboratory data of patients).
Cohort A
The checklist (basic) is filled out for all patients with postoperative complications. At the same time, the total number of patients operated on in a particular center is taken into account on a quarterly basis, taking into account their distribution by area of surgery. Based on the data from the basic checklist, answers will be received to the following target points:
1. Creation of a national register of postoperative outcomes in different areas of surgery.
2. Determination of the frequency and structure of outcomes after planned and emergency surgical interventions.
3. Analysis of long-term results in patients with postoperative complications (90 days and a year after surgery)
4. Analysis of the course of ICU-syndrome in patients with complications and depending on the maximum score on the scale and the structure of MOF in the postoperative period
5. Analysis of the effectiveness of rehabilitation measures in patients with ICU syndrome
Cohort B Basic checklist plus additional checklist: completed for all operated patients within one selected week quarterly The total number of patients operated on in a particular center is also taken into account quarterly, taking into account their distribution by area of surgery.
Based on the data from the basic and additional checklists, answers to the most important target points (3 primary and 10 secondary) will be obtained:
1. Identification of predictors of unfavorable outcome.
2. Development and validation of a model for predicting complications and mortality in various fields of surgery
3. Creation of calculators for the risk of postoperative complications and mortality in various fields of surgery and their integration into a single calculator
4. The role of concomitant diseases in the development of unfavorable outcome
5. The influence of age on primary and secondary postoperative outcomes
6. The influence of the type of anesthesia on the course of the postoperative period
7. The influence of oncological pathology and specific treatment on primary and secondary postoperative outcomes
8. The impact of the urgency of surgery on the risk of an unfavorable outcome
9. The influence of localization, access and duration of surgery on postoperative outcome
10. Assessment and validation of surgical and anesthesiological risk scales for lethal outcome (can be listed)
11. Evaluation and validation of surgical and anesthetic risk scales for primary and secondary outcomes
12. Stratification of patients at high perioperative risk with details on cardiac, respiratory, neurological, renal, hepatic, hemostasiological, infectious and others.
13. Influence of quality criteria for implementation of FAR recommendations on the course of the postoperative period
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort A
A cohort in which the incidence of the primary outcomes in the study population will be assessed.
No interventions assigned to this group
Cohort B
A cohort in which risk factors for primary outcomes will be identified, and a risk calculator for their development will be developed and validated
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In obstetrics
* In gynecology
* Breast
* In urology and kidneys
* In endocrine surgery
* In maxillofacial surgery
* In orthopedics and traumatology
* On the lower abdominal cavity
* On the liver and biliary tract
* On the upper abdominal cavity
* In thoracic surgery
* In vascular surgery
* In neurosurgery
* In cardiac surgery
* In other areas (with mandatory specification)
* Adult patients (age 18 years and older) undergoing emergency surgery in the listed and other areas of surgery (for example, in purulent surgery).
Exclusion Criteria
2. Complications associated with the manipulations of an anesthesiologist
3. Interventions without the participation of an anesthesiologist-resuscitator
4. Incomplete checklists
5. Errors when filling checklists
6. Deviations from the Register protocol
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kuban State Medical University
OTHER
Russian Federation of Anesthesiologists and Reanimatologists
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexey Shchegolev, MD
Role: STUDY_DIRECTOR
Military Medical Academy, Bulgaria
Konstantin Lebedinskii, MD
Role: STUDY_DIRECTOR
North-Western State Medical University named after Ilya I. Mechnikov
Igor Zabolotskikh, MD
Role: STUDY_CHAIR
Kuban State Medical University
Nikita Trembach, MD
Role: STUDY_DIRECTOR
Kuban State Medical University
Andrey Belkin, MD
Role: STUDY_DIRECTOR
Clinical Institute of Brain
Evgeniy Grigiriev, MD
Role: STUDY_DIRECTOR
Research Institute for Complex Issues of Cardiovascular Diseases
Alexei Gritsan, MD
Role: STUDY_DIRECTOR
Voino-Yasenetsky Krasnoyarsk State Medical University
Pavel Dunts, PhD
Role: STUDY_DIRECTOR
Pacific State Medical University
Vadim Ershov, MD
Role: STUDY_DIRECTOR
Orenburg State Medical University
Mikhail Kirov, MD
Role: STUDY_DIRECTOR
Northern State Medical University
Artem Kuzovlev, MD
Role: STUDY_DIRECTOR
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
Alexandr Kulikov, MD
Role: STUDY_DIRECTOR
Ural State Medical University
Alexey Ovezov, MD
Role: STUDY_DIRECTOR
Moscow Regional Research and Clinical Institute
Denis Protsenko, MD
Role: STUDY_DIRECTOR
Pirogov Russian National Research Medical University
Valeriy Subbotin, MD
Role: STUDY_DIRECTOR
Loginov Moscow Clinical Scientific Center
Victoria Khoronenko, MD
Role: STUDY_DIRECTOR
P. A. Hertsen Moscow Oncology Research Center
Efim Shifman, MD
Role: STUDY_DIRECTOR
Moscow Regional Research and Clinical Institute, Moscow, Russia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First City Clinical Hospital. n.a. E. E. Volosevich
Arkhangelsk, , Russia
Kuzbass Clinical Emergency Hospital named after M.A. Podgorbunsky
Kemerovo, , Russia
Regional clinical hospital №2
Krasnodar, , Russia
Kuban State Medical University
Krasnodar, , Russia
Krasnodar regional hospital №2 (Kuban State Medical University)
Krasnodar, , Russia
Regional clinical hospital
Krasnoyarsk, , Russia
Federal research and clinical center of intensive care medicine and rehabilitology
Moscow, , Russia
Loginov Moscow Clinical Scientific Center
Moscow, , Russia
Military Medical Academy
Moscow, , Russia
Moscow cancer research Institute named after P. A. Herzen
Moscow, , Russia
Moscow Regional Research and Clinical Institute, Moscow, Russia
Moscow, , Russia
Moscow regional research clinical Institute named after M. F. Vladimirsky
Moscow, , Russia
Orenburg City N.I. Pirogov Clinical Hospital
Orenburg, , Russia
North-Western State Medical University named after Ilya I. Mechnikov,
Saint Petersburg, , Russia
Regional clinical hospital №2
Vladivostok, , Russia
Clinical city hospital № 40
Yekaterinburg, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mikhail Kirov, MD
Role: primary
Evgeny Grigoriev
Role: primary
Igor Zabolotskikh, MD
Role: primary
Alexey Gritsan
Role: primary
Artem Kuzovlev
Role: primary
Valeriy Subbotin, MD
Role: primary
Alexey Shchegolev, MD
Role: primary
Efim Shifman, MD
Role: primary
Vadim Ershov
Role: primary
Konstantin Lebedinsii, MD
Role: primary
Andrey Belkin, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FARCT0005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.